Cite Filings / MCRB / 0000950170-24-019351
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
PRE 14A

Proxy Statement (Preliminary)

Seres Therapeutics, Inc. · Filed 2024-02-23 · Acc 0000950170-24-019351

Documents 1

  • PRE 14A Proxy Statement (Preliminary) , mcrb-20240222.htm

Around this filing

  • 2025-03-03 PRE 14A Proxy Statement (Preliminary)
  • 2024-02-26 8-K Executive or director change · Regulation FD disclosure
  • 2024-02-23 PRE 14A Proxy Statement (Preliminary)
  • 2024-02-16 4 Chief Legal Officer and EVP sold 3,939 shares at $1.08 ($4,254)
  • 2024-02-16 4 CEO and President sold 11,549 shares at $1.08 ($12,473)
  • 2024-02-16 4 Henn Matthew R. sold 4,170 shares at $1.08 ($4,504)
  • 2023-04-14 PRE 14A Proxy Statement (Preliminary)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading mcrb-20240222.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…